IGI, Laboratories, Inc. announced it has submitted an additional abbreviated new drug application (ANDA) to the US FDA, which brings the company's total number of submissions to nine.
IGI, Laboratories, Inc. announced it has submitted an additional abbreviated new drug application (ANDA) to the US FDA, which brings the company's total number of submissions to nine.